Preview

Eurasian heart journal

Advanced search

Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers

https://doi.org/10.38109/2225-1685-2024-1-126-132

Abstract

The volume of the left atrium is one of the key factors associated with both the development of primary atrial fibrillation and its progression. Open atrial communication is considered as a factor predisposing to dilation and remodeling of the heart cavities. We present a clinical case of endovascular closure of an open oval window in a patient with a persistent form of AF, a moderately reduced left ventricular ejection fraction, who had previously undergone radiofrequency ablation, and persistent manifestations of heart failure. A 58-year-old patient was hospitalized in November 2019 with clinical manifestations of increasing heart failure. History: persistent form of atrial fibrillation with pronounced ventricular tachysystole. In April 2019, the patient underwent radiofrequency ablation, during which signs of open oval window were revealed. The initial left ventricular ejection fraction is 41%, the anterior–posterior left atrium size is 47 mm, the NT-proBNP level is 912 pg/m. In the subsequent period, steady sine waves were recorded.

About the Authors

A. S. Tereshchenko
E.I. Chazov National Medical Research Center of cardiology
Russian Federation

Andrey S. Tereshchenko, Cand. of Sci. (Med.), Senior Researcher, the Department of X-ray Endovascular Methods of Diagnosis and Treatment

St. Academician Chazova, 15 a, Moscow 121552



E. G. Zhelyakov
N.I. Pirogov Russian National Research Medical University; JSC «Medicine»
Russian Federation

Evgeny G. Zhelyakov, Cand. of Sci. (Med.), Cardiologist, Associate Professor, the Department of Cardiovascular surgery faculty of Postgraduate and Continuing Education; cardiologist

Ostrovitianov str. 1, Moscow 117997

2nd Tverskaya-Yamskaya lane, 10, Moscow, 125047



E. V. Merkulov
E.I. Chazov National Medical Research Center of cardiology
Russian Federation

Evgeny V. Merkulov, Dr. of Sci. (Med.), Chief Researcher, the Department of X-ray Endovascular Methods of Diagnosis and Treatment

St. Academician Chazova, 15 a, Moscow 121552



D. V. Puzenko
N.I. Pirogov Russian National Research Medical University
Russian Federation

Dmitry V. Puzenko, Cand. of Sci. (Med.), cardiovascular surgeon, Head of the Department of Cardiovascular surgery, faculty of Postgraduate and Continuing Education

Ostrovitianov str. 1, Moscow 117997



O. V. Strunin
JSC «Medicine»; Peoples' Friendship University of Russia
Russian Federation

Oleg V. Strunin, Dr. of Sci. (Med.), anesthesiologist-resuscitator; Professor, the Department of Anesthesiology and Resuscitation with a rehabilitation course

2nd Tverskaya-Yamskaya lane, 10, Moscow, 125047

61 Vavilova str., p. 1, Moscow 117292



A. V. Ardashev
Feinberg Medical School
Russian Federation

Andrey V. Ardashev, Dr. of Sci. (Med.), Professor of Cardiology

Arthur J. Rubloff Building, 420 E. Superior St., Chicago, IL 60611



References

1. Nielsen J.C., Lin Y.J., de Oliveira Figueiredo M.J. et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. EP Eur. 2020;22:1147–8. https://doi.org/10.1093/EUROPACE/EUAA065

2. Packer D.L., Mark D.B., Robb R.A. et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321:1261–74. https://doi.org/10.1001/JAMA.2019.0693

3. Pathak R.K., Middeldorp M.E., Meredith M. et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65:2159–69. https://doi.org/10.1016/J.JACC.2015.03.002

4. January C.T., Wann L.S., Calkins H. et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104–32. https://doi.org/10.1016/J.JACC.2019.01.011

5. Aquino G.J., Chamberlin J., Yacoub B. et al. Diagnostic accuracy and performance of artificial intelligence in measuring left atrial volumes and function on multiphasic CT in patients with atrial fibrillation. Eur Radiol. 2022;32:5256–64. https://doi.org/10.1007/S00330-022-08657-Y/METRICS

6. Stojanovska J., Cronin P., Gross B.H. et al. Left Atrial Function and Maximum Volume as Determined by MDCT Are Independently Associated with Atrial Fibrillation. Acad Radiol. 2014;21:1162–71. https://doi.org/10.1016/J.ACRA.2014.02.018

7. Njoku A., Kannabhiran M., Arora R. et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a metaanalysis. EP Eur. 2018;20:33–42. https://doi.org/10.1093/EUROPACE/EUX013

8. Bajraktari G., Bytyçi I., Henein M.Y. Left atrial structure and function predictors of recurrent fibrillation after catheter ablation: a systematic review and meta-analysis. Clin Physiol Funct Imaging. 2020;40:1–13. https://doi.org/10.1111/CPF.12595

9. Wilmshurst P.T., De Belder M.A. Patent foramen ovale in adult life. Br Heart J. 1994;71:209. https://doi.org/10.1136/HRT.71.3.209

10. Kheiwa A., Hari P., Madabhushi P. et al. Patent foramen ovale and atrial septal defect. Echocardiography. 2020;37:2172–84. https://doi.org/10.1111/ECHO.14646

11. Kiełbasa G., Bednarek A., Bednarski A. et al. Patent foramen ovale and left atrial appendage flow velocity predict atrial fibrillation recurrence post cryoballoon ablation. Kardiol Pol (Polish Heart Journal). 2021;79:756–64. https://doi.org/10.33963/KP.A2021.0004

12. Berthet K., Lavergne T., Cohen A. et al. Significant Association of Atrial Vulnerability With Atrial Septal Abnormalities in Young Patients With Ischemic Stroke of Unknown Cause. Stroke. 2000;31:398–403. https://doi.org/10.1161/01.STR.31.2.398

13. Lechat P., Mas J.L., Lascault G. et al. Prevalence of Patent Foramen Ovale in Patients with Stroke. N Engl J Med. 1988;318:1148–52. https://doi.org/10.1056/NEJM198805053181802

14. De Castro S., Cartoni D., Fiorelli M. et al. Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications. Stroke. 2000;31:2407–13. https://doi.org/10.1161/01. STR.31.10.2407

15. Kavinsky C.J., Szerlip M., Goldsweig A.M. et al. SCAI Guidelines for the Management of Patent Foramen Ovale. J Soc Cardiovasc Angiogr Interv. 2022;1. https://doi.org/10.1016/j.jscai.2022.100039

16. Rigatelli G., Aggio S., Cardaioli P. et al. Left Atrial Dysfunction in Patients With Patent Foramen Ovale and Atrial Septal Aneurysm: An Alternative Concurrent Mechanism for Arterial Embolism? JACC Cardiovasc Interv. 2009;6:195–8. https://doi.org/10.1016/J.JCIN.2009.05.010

17. Rigatelli G., Zuin M., Adami A. et al. Left atrial enlargement as a maker of significant high-risk patent foramen ovale. Int J Cardiovasc Imaging. 2019;35:2049–56. https://doi.org/10.1007/S10554-019-01666-X/METRICS

18. Aslan M., Erturk M., Turen S. et al. Effects of percutaneous closure of atrial septal defect on left atrial mechanical and conduction functions. Eur Hear J – Cardiovasc Imaging. 2014;15:1117–24. https://doi.org/10.1093/EHJCI/JEU089

19. Rigatelli G., Dell’Avvocata F., Cardaioli P. et al. Long-term results of the amplatzer cribriform occluder for patent foramen ovale with associated atrial septal aneurysm: impact on occlusion rate and left atrial functional remodelling. Am J Cardiovasc Dis. 2012;2:68

20. Knecht S., Wright M., Lellouche N. et al. Impact of a Patent Foramen Ovale on Paroxysmal Atrial Fibrillation Ablation. J Cardiovasc Electrophysiol. 2008;19:1236–41. https://doi.org/10.1111/J.1540-8167.2008.01260.X.

21. Hildick-Smith D., Williams T.M. Patent Foramen Ovale and Migraine Headache. Interv Cardiol Clin. 2017;6:539–45. https://doi.org/10.1016/j.iccl.2017.05.006

22. Furlan A.J., Reisman M., Massaro J. et al. Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale. N Engl J Med. 2012;366:991–9. https://doi.org/10.1056/NEJMOA1009639/SUPPL_FILE/NEJMOA1009639_DISCLOSURES.PDF

23. Carpenter A., Crowther O., Gall A. et al. 138 Natural history of atrial fibrillation and atrial fibrillation ablation in patients undergoing percutaneous atrial septal defect closure. Heart. 2019;105:A114– A114. https://doi.org/10.1136/HEARTJNL-2019-BCS.135

24. Vecht J.A., Saso S., Rao C. et al. Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis. Heart. 2010;96:1789–97. https://doi.org/10.1136/HRT.2010.204933

25. Jarral O.A., Saso S., Vecht J.A. et al. Does patent foramen ovale closure have an anti-arrhythmic effect? A meta-analysis. Int J Cardiol. 2011;153:4–9. https://doi.org/10.1016/J.IJCARD.2011.02.027

26. Saver J.L., Carroll J.D., Thaler D.E. et al. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017;377:1022–32. https://doi.org/10.1056/NEJMOA1610057/SUPPL_FILE/NEJMOA1610057_DISCLOSURES.PDF


Review

For citations:


Tereshchenko A.S., Zhelyakov E.G., Merkulov E.V., Puzenko D.V., Strunin O.V., Ardashev A.V. Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers. Eurasian heart journal. 2024;(1):126-132. (In Russ.) https://doi.org/10.38109/2225-1685-2024-1-126-132

Views: 448


ISSN 2225-1685 (Print)
ISSN 2305-0748 (Online)